Rubric Capital Management LP - Aug 13, 2025 Form 4 Insider Report for COLLEGIUM PHARMACEUTICAL, INC (COLL)

Role
10%+ Owner
Signature
Rubric Capital Management LP, By: /s/ Michael Nachmani, its Chief Operating Officer
Stock symbol
COLL
Transactions as of
Aug 13, 2025
Transactions value $
-$946,250
Form type
4
Date filed
8/15/2025, 04:12 PM
Previous filing
Aug 12, 2025
SEC
View on sec.gov

Reporting Owners (2)

Name Relationship Address Signature Signature date CIK
Rubric Capital Management LP 10%+ Owner 155 EAST 44TH ST, SUITE 1630, NEW YORK Rubric Capital Management LP, By: /s/ Michael Nachmani, its Chief Operating Officer 2025-08-15 0001687509
Rosen David Efraim 10%+ Owner 155 EAST 44TH ST., SUITE 1630, NEW YORK /s/ David Rosen 2025-08-15 0001898677

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction COLL Common Stock, par value $0.001 per share Sale -$946K -25K -0.79% $37.85 3.13M Aug 13, 2025 See footnotes F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Rubric Capital Management LP is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 This Form 4 is filed by Rubric Capital Management LP ("Rubric Capital") and Mr. David Rosen, with respect to the securities held by certain funds and/or accounts (collectively, the "Rubric Vehicles"). Rubric Capital serves as the investment adviser to the Rubric Vehicles. Mr. David Rosen serves as the Managing Member of Rubric Capital Management GP, LLC, the general partner of Rubric Capital.
F2 The filing of this statement shall not be deemed an admission that any Reporting Person is the beneficial owner of the securities reported herein for purposes of Section 16 of the Securities Act of 1934, as amended, or otherwise. Each Reporting Person expressly disclaims beneficial ownership of the securities reported herein except to the extent of its or his pecuniary interest therein, if any.
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.71 to $38.10, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.